270 related articles for article (PubMed ID: 23171154)
1. Resistance profiles of urinary tract infections in general practice--an observational study.
Schmiemann G; Gágyor I; Hummers-Pradier E; Bleidorn J
BMC Urol; 2012 Nov; 12():33. PubMed ID: 23171154
[TBL] [Abstract][Full Text] [Related]
2. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
Aris P; Boroumand MA; Rahbar M; Douraghi M
Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
[TBL] [Abstract][Full Text] [Related]
3. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020.
Salm J; Salm F; Arendarski P; Kramer TS
Euro Surveill; 2022 Jul; 27(30):. PubMed ID: 35904060
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
5. Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study.
Matthews PC; Barrett LK; Warren S; Stoesser N; Snelling M; Scarborough M; Jones N
BMC Infect Dis; 2016 Oct; 16(1):556. PubMed ID: 27729016
[TBL] [Abstract][Full Text] [Related]
6. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
[TBL] [Abstract][Full Text] [Related]
7. Uncomplicated urinary tract infections in Swedish primary care; etiology, resistance and treatment.
Kornfält Isberg H; Melander E; Hedin K; Mölstad S; Beckman A
BMC Infect Dis; 2019 Feb; 19(1):155. PubMed ID: 30760219
[TBL] [Abstract][Full Text] [Related]
8. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
Lishman H; Costelloe C; Hopkins S; Johnson AP; Hope R; Guy R; Muller-Pebody B; Holmes A; Aylin P
Int J Antimicrob Agents; 2018 Dec; 52(6):790-798. PubMed ID: 30145249
[TBL] [Abstract][Full Text] [Related]
9. A cost-minimization analysis of treatment options for postmenopausal women with dysuria.
Bradley MS; Beigi RH; Shepherd JP
Am J Obstet Gynecol; 2019 Nov; 221(5):505.e1-505.e7. PubMed ID: 31055032
[TBL] [Abstract][Full Text] [Related]
10. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
11. [Urinary tract pathogens in uncomplicated lower urinary tract infections in women in Norway].
Jureen R; Digranes A; Baerheim A
Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2021-2. PubMed ID: 12934120
[TBL] [Abstract][Full Text] [Related]
12. Impact of long-term care facility residence on the antibiotic resistance of urinary tract Escherichia coli and Klebsiella.
Rosello A; Hayward AC; Hopkins S; Horner C; Ironmonger D; Hawkey PM; Deeny SR
J Antimicrob Chemother; 2017 Apr; 72(4):1184-1192. PubMed ID: 28077671
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
14. An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn R; McDermott TE; Murphy P; Grainger R; Fennell JP; Thornhill JA
Ir J Med Sci; 2013 Mar; 182(1):81-9. PubMed ID: 22669684
[TBL] [Abstract][Full Text] [Related]
15. TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE AND FOSFOMYCIN SUSCEPTIBILITY RATES IN UNCOMPLICATED URINARY TRACT INFECTIONS: TIME TO CHANGE THE ANTIMICROBIAL PREFERENCES.
Guneysel O; Suman E; Ozturk TC
Acta Clin Croat; 2016 Mar; 55(1):49-57. PubMed ID: 27333718
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.
Fedrigo NH; Mazucheli J; Albiero J; Shinohara DR; Lodi FG; Machado ACDS; Sy SKB; Tognim MCB
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607025
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
Yeshitela B; Gebre-Selassie S; Feleke Y
Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
[TBL] [Abstract][Full Text] [Related]
19. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
Valentine-King M; Zoorob R; Grigoryan L; Trautner B
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944052
[TBL] [Abstract][Full Text] [Related]
20. Escherichia coli and Klebsiella pneumoniae Sensitivity/Resistance Pattern Towards Antimicrobial Agents in Primary and Simple Urinary Tract Infection Patients Visiting University Hospital of Jamia Hamdard New Delhi.
Rizwan M; Akhtar M; Najmi AK; Singh K
Drug Res (Stuttg); 2018 Jul; 68(7):415-420. PubMed ID: 29529677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
